DLK1 and Nesfatin-1 levels and the relationship with metabolic parameters in polycystic ovary syndrome: Prospective, controlled study

Creative Commons License

Caltekin M. D., Caniklioglu A., Yalcin S. E., Kirmizi D. A., BAŞER E., YALVAÇ E. S.

TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, vol.18, no.2, pp.124-130, 2021 (ESCI, Scopus, TRDizin)

  • Publication Type: Article / Article
  • Volume: 18 Issue: 2
  • Publication Date: 2021
  • Doi Number: 10.4274/tjod.galenos.2021.39024
  • Journal Name: TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.124-130
  • Keywords: Polycystic ovary syndrome, delta-like 1, nesfatin-1, visceral adiposity index, insulin resistance, INSULIN-RESISTANCE, ACTIVATION, MARKERS, OBESITY
  • Open Archive Collection: AVESIS Open Access Collection
  • Yozgat Bozok University Affiliated: Yes

Abstract

Objective: Delta-like 1 (DLK1) is known to inhibit adipocyte differentiation and nesfatin-1 is a neuropeptide that plays a role in the regulation of nutrition and metabolism. We aimed to assess both the levels of DLK1 and nesfatin-1 in polycystic ovary syndrome (PCOS) and determine the association of DLK1 and nesfatin-1 with metabolic parameters.